Stocks recover as U.S. stimulus offsets angst over new coronavirus
strain
Send a link to a friend
[December 22, 2020] By
Tom Wilson
LONDON (Reuters) -Stocks rebounded on
Tuesday, with Washington's approval of an $892 billion pandemic relief
package helping them recover some of the losses caused by fears over a
highly infectious new strain of COVID-19.
The Euro STOXX 600 added 0.8%, its biggest one-day jump in over five
weeks in sight. German and French indexes added 1% and 0.8%
respectively.
London's blue chips turned positive, too, recovering early losses even
as Britain adjusts to strict lockdowns imposed to curb the spread of the
new strain of coronavirus. Wall Street futures also edged into the
black.
Fuelling the optimism, in part, was the U.S. Congress's approval on
Monday of a coronavirus aid package after months of inaction. The first
such aid since April came as the pandemic accelerated in the United
States, infecting more than 214,000 people every day and slowing the
economic recovery.
The bill includes $600 payments to most Americans and additional
payments to millions of people thrown out of work during the pandemic.
Market players also took stock of the damage from a new COVID-19
variant, with investors betting that vaccines would still be effective
against the new strain.
On Monday, countries across the world shut their borders to Britain
because of fears over the new strain, snarling one of Europe's most
important trade routes just days before Britain is set to leave the
European Union.
The discovery, just months before vaccines are expected to be widely
available, brought back fears over the economic impact of new lockdowns
to counter the virus, which has killed about 1.7 million people
worldwide.
European shares had slumped 2.3%, their biggest one-day loss in nearly
two months, in response.
The new strain "is a bump in the road, but that road is still leading to
a much stronger recovery in the second half of next year," said Hugh
Gimber, global market strategist at J.P. Morgan Asset Management.
[to top of second column] |
People wearing protective face masks, following an outbreak of the
coronavirus, are reflected on a screen showing Nikkei index, outside
a brokerage in Tokyo, Japan February 28, 2020. REUTERS/Athit
Perawongmetha
"Markets are a lot calmer today because of confidence that there is a big build
up of pent-up demand and a return to much stronger levels of activity in the
second half of next year."
The MSCI world equity index, which tracks shares in 49 countries, was flat.
Earlier, MSCI's gauge of Asia-Pacific stocks outside Japan had sunk 0.8%.
THE POUND'S PROSPECTS
The stimulus news helped prop up the dollar index, which was still on course for
a third consecutive quarterly loss after dropping some 12.5% from a March peak.
The index, which measures the dollar against a basket of six major currencies,
was last up 0.1% at 90.232, still below its Monday top of 90.978.
ING analysts said the U.S. relief package "won't be able to fully offset the
effects of people staying at home as many businesses face tighter restrictions
or are even forced to close."
In Britain, sterling slipped 0.5% after tumbling as much as 2.5% versus the
dollar on Monday to a 10-day low amid the twin fears over COVID and Brexit.
European Commission President Ursula von der Leyen and British Prime Minister
Boris Johnson spoke on disagreements over fisheries that are barring a new trade
deal, sources said.
Analysts remained pessimistic on the pound's prospects, even after reports of
progress in Brexit trade talks.
MUFG said in a note to clients it expected London and Brussels would strike a
last-minute deal, but added: "Even if a trade deal is reached, upside potential
for the pound will now be dampened by recent negative COVID developments in the
UK."
(Reporting by Tom Wilson in London; editing by Larry King)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |